Clinical Trial Update: French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

View source ↗

Summary

A French study (FRENCH.MRD.PDAC) is evaluating minimal residual disease by liquid biopsies, including ctDNA, in patients with resectable pancreatic ductal adeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Pancreatic Cancer Resectable, Pancreatic Ductal Adenocarcinoma | Status: RECRUITING